Skip to main content
Equibles
VCEL logo

VCEL · Vericel Corp · Metrics

Track VCEL — free

Use VCEL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VCEL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$40.58 +0.00 (+0.00%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.09B
Shares
51.21M
Volume · Oct 20 475.27K Avg daily vol (3M) 509.5K

VCEL metrics

95 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$40.58
Market cap
$2.09B

Price action

20 metrics
Price change (1W)
+0.7%
Price change (30D)
+2.6%
Price change (3M)
-12.1%
Price change (6M)
+20.5%
Price change (YTD)
+12.7%
Price change (1Y)
+12.7%
Trailing year
Price change (5Y)
-20.0%
52-week high
$48.31
52-week low
$29.34
Change from 52-week high
-16.0%
Change from 52-week low
+38.3%
Annualized volatility
40.5%
Annualized volatility (3M)
27.4%
Beta
0.8
RSI (14D)
51.0
Price vs SMA 50
-0.7%
Price vs SMA 200
+5.4%
Avg volume (3M)
509,500
Relative volume
0.9
Average dollar volume
$21.37M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
51.21M

Valuation

12 metrics
P / E (TTM)
84.5
Trailing earnings · reciprocal yield 1.2%
PEG ratio
1.4
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
6.8×
reciprocal yield 14.7%
P / book
5.6
reciprocal yield 17.7%
FCF yield
3.0%
TTM · current market cap
Buyback yield
—
P / FCF
33.8
reciprocal yield 3.0%
P / operating cash flow
29.9
reciprocal yield 3.3%
Earnings yield
1.2%

Historical valuation

8 metrics
P / E historical average (3Y)
955.3×
reciprocal yield 0.1%
P / E historical average (5Y)
955.3×
reciprocal yield 0.1%
EV / revenue historical average (3Y)
10.1×
reciprocal yield 9.9%
EV / revenue historical average (5Y)
10.1×
reciprocal yield 9.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
74.6%
Operating margin
6.0%
Trailing 12 months
Net margin
7.9%
Gross profit (TTM)
$228.38M
Operating profit (TTM)
$18.23M
Net income (TTM)
$24.22M
Trailing 12 months
Diluted EPS (TTM)
$0.48
FCF margin
20.1%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$5.78
Gross profit per diluted share (TTM)
$4.30
Operating profit per diluted share (TTM)
$0.31
EBITDA per diluted share (TTM)
$0.56
Net income per diluted share (TTM)
$0.43
Operating cash flow per diluted share (TTM)
$1.32
Free cash flow per diluted share (TTM)
$1.17
Capital expenditures per diluted share (TTM)
$0.15
R&D per diluted share (TTM)
$0.55
Stock compensation per diluted share (TTM)
$0.71
Book value per share
$7.01

Growth

11 metrics
Revenue growth YoY
+22.5%
Year over year
Net income growth YoY
+59.4%
Revenue (TTM)
$306.30M
Trailing 12 months
EPS growth YoY
+60.0%
Shares change YoY
+3.9%
Year over year · more shares
Revenue CAGR (3Y)
+18.9%
Revenue CAGR (5Y)
+17.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
+39.8%
FCF CAGR (3Y)
+34.9%
FCF CAGR (5Y)
+10.6%

Quality

14 metrics
Return on equity
6.5%
Return on assets
4.8%
Debt / equity
—
Current ratio
5.0
EBITDA (TTM)
$31.15M
Free cash flow (TTM)
$61.66M
Quick ratio
4.7
Interest coverage
28.5
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$125.36M
Total assets
$502.87M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$69.67M
Capital expenditures (TTM)
$8.01M
R&D (TTM)
$29.17M
SG&A (TTM)
$180.98M
Stock compensation (TTM)
$37.50M
R&D / revenue
9.5%
Stock compensation / revenue
12.2%

Ownership (13F)

9 metrics
13F filers
321
13F filer change QoQ
+39
Institutional ownership
108.6%
Conviction holders (share of 13F filers)
0.6%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-1.9%
Holder tenure
14.7
Price vs estimated holder cost
+16.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
27.2%

Short interest

3 metrics
Short interest
10.2%
Latest settlement · 9.6 days to cover
Days to cover
9.6d
Short-squeeze score
69 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.00M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 887359 CUSIP 92346J108 13F (30d) 31 filings 31 filers Visit website Investor relations